Javelin Biotech

Javelin Biotech is a commercial-stage technology company developing predictive drug discovery platforms that merge human tissue chips with computational biology & machine learning to greatly improve preclinical R&D productivity and reduce reliance on animal studies. Its first product (pharmacokinetics platform) is developed in partnership with Pfizer. This platform can deliver clinical predictions that are 33% more accurate, 10x faster, and cheaper than rat pharmacokinetic studies, potentially replacing over one million animal-based PK studies per year.